International Flavors & Fragrances Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

IFF Divests Botanical Extracts, Vitamins, and Food Enhancement Business ...

AI-generated analysis

🀝 IFF has reached a definitive agreement to divest its botanical extracts, vitamins, food enhancement, natural colors, and certain Peru flavor operations.

🏒 The buyer is SuanNutra, a Madrid-based portfolio company owned by German private equity firm Carbyne Equity Partners.

πŸ’° The targeted business portfolio generated approximately $170 million in revenue during the 2025 fiscal year.

πŸ‘₯ The divested operations collectively employ roughly 600 individuals across five production sites spanning Europe, the U.S., and Latin America.

πŸ“… IFF expects to finalize the transaction by the close of 2026 pending regulatory approvals and standard closing conditions.

πŸ›οΈ Alantra served as the financial advisor for IFF while DLA Piper LLP provided legal counsel for the deal.

Bullish Signals
  • πŸ’° The divestiture allows IFF to unlock value from non-core assets, potentially freeing up capital for strategic reinvestment or debt reduction.
  • πŸ“‰ Selling a $170 million revenue stream with 600 employees suggests the company is successfully managing its portfolio size and focusing on core competencies.
Risk Factors
  • πŸ“‰ The financial specifics of the sale price remain undisclosed, preventing immediate assessment of whether the deal represents a premium or discount relative to market expectations.
Full Analysis
International Flavors & Fragrances (IFF) has agreed to sell a significant portfolio of businesses including botanical extracts, vitamins, minerals, natural colors, antioxidants, and specific flavor operations in Peru to SuanNutra. SuanNutra is a portfolio company of Carbyne Equity Partners, with the transaction facilitated by financial advisor Alantra and legal counsel DLA Piper LLP. The divested business units serve diverse food, beverage, and nutritional markets through tailored solutions. The portfolio generated approximately $170 million in revenue during 2025 and employs roughly 600 individuals across five production sites located in Europe, the United States, and Latin America. IFF anticipates finalizing the sale by the close of 2026, subject to standard closing conditions including regulatory approvals and necessary consultation processes. The financial specifics of the transaction value remain undisclosed at this time.